BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 1543518)

  • 21. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
    Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Otologic manifestation of Wegener granulomatosis].
    Frank W; Münzel M
    Laryngol Rhinol Otol (Stuttg); 1985 Oct; 64(10):527-31. PubMed ID: 4068857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anticytoplasmic antibodies as serological markers and activity parameters of Wegener's granulomatosis. A prospective study].
    Lüdemann G; Nölle B; Rautmann A; Rosenboom S; Kekow J; Gross WL
    Dtsch Med Wochenschr; 1988 Mar; 113(11):413-7. PubMed ID: 3280286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learnt in the management of Wegener's Granulomatosis: long-term follow-up of 60 patients.
    Sproson EL; Jones NS; Al-Deiri M; Lanyon P
    Rhinology; 2007 Mar; 45(1):63-7. PubMed ID: 17432073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Wegener's granulomatosis and anti-cytoplasm antibodies].
    Göbel U; Briedigkeit L; Voigt B; Kettritz R; Schöntube M; Natusch R
    Z Gesamte Inn Med; 1990 Nov; 45(21):638-43. PubMed ID: 2099017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Otologic manifestations of Wegener's disease].
    Verfaillie J; Clarysse J; Loncke R; Tanghe W
    Acta Otorhinolaryngol Belg; 1992; 46(4):369-73. PubMed ID: 1462776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study.
    Bindi P; Mougenot B; Mentre F; Noel LH; Peraldi MN; Vanhille P; Lesavre P; Mignon F; Ronco PM
    Q J Med; 1993 Jan; 86(1):55-68. PubMed ID: 8438051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
    Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
    Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intervention in localized Wegener's granulomatosis with sensorineural hearing loss preserves hearing.
    Sriskandarajah V; Bansal RA; Yeoh R; Bansal AS
    Am J Audiol; 2012 Dec; 21(2):121-6. PubMed ID: 22718321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neutrophil anticytoplasmic antibodies in a patient with Wegener's granulomatosis: therapeutic implications of its detection and relation to clinical activity].
    Bosch X; Forns X; Font J; Mirapeix E; Revert L; Ingelmo M
    Med Clin (Barc); 1991 Dec; 97(20):780-2. PubMed ID: 1795572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wegener's granulomatosis presenting as acute systemic vasculitis following 20 years of limited tracheobronchial disease.
    Peters JE; Salama AD; Ind PW
    J Laryngol Otol; 2009 Dec; 123(12):1375-7. PubMed ID: 19175952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Infectious aspects of Wegener's granulomatosis].
    Rusterholz D; Schlegel C
    Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Wegener's granulomatosis: ocular manifestations, diagnosis and therapy].
    Duncker G; Beigel A; Lehmann H
    Klin Monbl Augenheilkd; 1982 Sep; 181(3):184-7. PubMed ID: 7144012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis--a clinical randomized controlled trial.
    Szpirt WM; Heaf JG; Petersen J
    Nephrol Dial Transplant; 2011 Jan; 26(1):206-13. PubMed ID: 20577017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Head and neck manifestations and management of Wegener's granulomatosis].
    Li Q; Zhang B; Peng P; Gao Z; Yin H; Feng G
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Dec; 19(24):1112-5. PubMed ID: 16512486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refractory otitis media: an unusual presentation of childhood granulomatosis with polyangiitis.
    Uppal P; Taitz J; Wainstein B; Soma M; Belessis Y; Gray P
    Pediatr Pulmonol; 2014 Mar; 49(3):E21-4. PubMed ID: 23359478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Severe Wegener's granulomatosis successfully treated with rituximab].
    Semenkova EN; Krivosheev OG; Novikov PI; Osipenko VI; Nosova NR; Parfenova SA; Nikiforova NV; Borodin OO
    Ter Arkh; 2010; 82(6):53-5. PubMed ID: 20731113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ACPA reaction in atypical Wegener's disease. Diagnostic test].
    Rump JA; Laaff H; Lang B; Schön S; Kuhlmann M; Solzbach U; Vaith P; Schollmeyer P; Peter HH
    Dtsch Med Wochenschr; 1989 Dec; 114(51-52):2008-13. PubMed ID: 2689129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wegener's granulomatosis and autoantibodies to neutrophil antigens.
    McCluskey DR; Maxwell AP; Watt L
    Ulster Med J; 1988 Oct; 57(2):137-40. PubMed ID: 3068870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.